Focused Wealth Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-400
| Closed | -$16.5K | – | 1054 |
|
2023
Q3 | $16.5K | Hold |
400
| – | – | ﹤0.01% | 453 |
|
2023
Q2 | $22.3K | Hold |
400
| – | – | ﹤0.01% | 417 |
|
2023
Q1 | $22.3K | Hold |
400
| – | – | ﹤0.01% | 430 |
|
2022
Q4 | $14.6K | Sell |
400
-2,355
| -85% | -$85.8K | ﹤0.01% | 462 |
|
2022
Q3 | $78K | Sell |
2,755
-135
| -5% | -$3.82K | 0.02% | 206 |
|
2022
Q2 | $131K | Sell |
2,890
-60
| -2% | -$2.72K | 0.02% | 163 |
|
2022
Q1 | $224K | Buy |
2,950
+15
| +0.5% | +$1.14K | 0.04% | 144 |
|
2021
Q4 | $437K | Sell |
2,935
-40
| -1% | -$5.96K | 0.07% | 107 |
|
2021
Q3 | $433K | Sell |
2,975
-190
| -6% | -$27.7K | 0.07% | 105 |
|
2021
Q2 | $620K | Sell |
3,165
-90
| -3% | -$17.6K | 0.1% | 84 |
|
2021
Q1 | $589K | Buy |
3,255
+155
| +5% | +$28K | 0.1% | 90 |
|
2020
Q4 | $439K | Buy |
+3,100
| New | +$439K | 0.09% | 102 |
|